Withings introduces the Body Scan 2, a $600 smart scale designed to provide comprehensive health insights by measuring over 60 biomarkers related to longevity and chronic illness risk. The device, equipped with medical-grade technologies, aims to help users spot early signs of health issues and make lifestyle adjustments for better long-term health outcomes.

The FDA has approved a breakthrough blood test for detecting Alzheimer's disease, which could help diagnose the condition earlier and more accurately. This test measures specific biomarkers associated with Alzheimer's, making it a significant advancement in the fight against the disease and potentially transforming how patients are treated.